POLARITYTE, INC. (PTE) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Oct-31-18	Oct-31-17	Oct-31-16	Oct-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Contract Services	0.8	6.3	6.4	3.3	0.9
Regenerative Medicine		3.1	3.7	2.4	0.7
Total revenues	0.8	9.4	10.1	5.7	1.6	0.0	4.1	6.7
Revenue growth [+]	-91.3%	-7.1%	79.2%			-100.0%	-38.8%	-80.5%
Contract Services	-87.1%	-1.1%	93.9%
Regenerative Medicine		-17.5%	58.5%
Cost of goods sold [+]	0.6	4.3	4.4	2.5	1.0	104.7	4.1	3.4
Cost of product sales								2.3
Gross profit	0.2	5.1	5.7	3.2	0.6	-104.7	0.0	3.3
Gross margin	24.3%	54.1%	56.3%	56.1%	35.9%		0.0%	48.9%
Selling, general and administrative [+]	15.0	23.3	36.3	80.2	50.6	18.8	4.1	6.1
Sales and marketing		2.8	8.7	17.0	2.4			0.8
General and administrative	15.0	20.5	27.6	63.2	48.3	18.8	4.1	5.4
Research and development	11.0	14.2	11.5	16.4	19.4	7.1		0.2
Equity in earnings
Other operating expenses							0.2	-0.7
EBITDA [+]	-24.4	-29.5	-38.8	-90.2	-67.9	-130.2		-1.9
EBITDA growth	-17.5%	-24.0%	-56.9%		-47.8%	2894.7%	130.6%	-66.8%
EBITDA margin	-2993.9%	-314.1%	-383.6%	-1596.0%	-4346.6%		-106.1%	-28.2%
Depreciation	1.5	2.7	3.1	3.0	1.4	0.4		0.1
EBITA	-25.9	-32.2	-41.9	-93.2	-69.3	-130.6	-4.3	-1.9
EBITA margin	-3179.0%	-342.3%	-414.0%	-1649.0%	-4435.8%		-106.1%	-29.1%
Amortization of intangibles		0.2	0.2	0.2	0.1			0.4
EBIT [+]	-25.9	-32.4	-42.1	-93.4	-69.4	-130.6	-4.3	-2.4
EBIT growth	-20.1%	-23.1%	-54.9%		-46.8%	2904.6%	82.8%	-86.1%
EBIT margin	-3179.0%	-344.3%	-415.8%	-1652.4%	-4442.2%		-106.1%	-35.5%
Non-recurring items [+]	-3.5	1.3	3.8				-0.2	1.5
Asset impairment	0.4	0.6
Loss (gain) on sale of assets	-4.0
Interest income, net [+]	0.0	-0.1	-0.2	0.2	0.4	0.0	0.0	0.0
Interest expense	0.0	0.1	0.2					0.0
Interest income				0.2	0.4	0.0	0.0
Other income (expense), net [+]	14.6	3.6	3.3	0.7	3.3	0.1	0.2	0.2
Gain (loss) on sale of assets								-0.1
Gain (loss) on debt retirement		3.6						1.5
Gain (loss) on derivative instruments		-5.2			3.8	0.1	0.2
Unrealized gain/loss on derivatives	14.5	5.0	2.9
Change in fair value of warrants	14.5	5.0	2.9			4.3	0.1	1.5
Other non-operating gains/losses								-0.2
Other non-operating income	0.1	0.2	0.4	0.7
Other	0.1	0.2	0.4	0.7				0.2
Pre-tax income	-7.8	-30.2	-42.9	-92.5	-65.7	-130.5	-3.8	-3.8
Income taxes	0.0	0.0	0.0	0.0	-0.3	0.3	0.8	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.5%
Earnings from continuing ops	-7.8	-30.2	-42.9	-92.5	-74.2	-131.0	-9.8	-6.1
Earnings from discontinued ops						-0.3	-0.8
Net income	-7.8	-30.2	-42.9	-92.5	-74.2	-131.3	-10.6	-6.1
Net margin	-962.3%	-321.0%	-423.2%	-1636.5%	-4744.8%		-259.6%	-90.6%

Basic EPS [+]	($1.14)	($9.43)	($1.11)	($3.70)	($4.86)	($26.60)	($4.69)	($4.93)
Growth	-87.9%	753.5%	-70.2%		-81.7%	466.9%	-4.9%	95.6%
Diluted EPS [+]	($1.02)	($9.43)	($1.09)	($3.70)	($4.86)	($26.60)	($4.69)	($4.93)
Growth	-89.2%	766.4%	-70.6%		-81.7%	466.9%	-4.9%	95.6%


Shares outstanding (basic) [+]	6.9	3.2	38.8	25.0	15.3	4.9	2.1	1.2
Growth	114.1%	-91.7%	55.3%		209.9%	134.9%	70.6%	-80.9%
Shares outstanding (diluted) [+]	7.7	3.2	39.4	25.0	15.3	4.9	2.1	1.2
Growth	139.5%	-91.9%	57.7%		209.9%	134.9%	70.6%	-80.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.